LONG BEACH, Calif.--(BUSINESS WIRE)--Jan 29, 2007 - Obagi Medical Products, Inc. (NASDAQ: OMPI), the leader in skin health, today announced the launch of a new acne therapy - CLENZIderm M.D.(TM) Acne Therapeutic System. The new physician dispensed acne system boasts an advanced, patent-pending Soluzyl Technology(TM) that liquefies Benzoyl Peroxide (BPO) on contact, resulting in greater follicular penetration and rapid lesion reduction.

"We are very excited to bring novel and efficacious technology to the field of acne treatment, a market valued at $1.3 billion," said Steven Carlson, President of Obagi Medial Products. "Studies indicate that no other single acne treatment or combination therapy is proven to work on all three causes of acne, including excess oil, acne-causing bacteria and clogged pores.

Britney Spears's Comeback Album Heading for Garbage Bin!

The 'Toxic singer has gone out almost every night since her spilt from failed rapper Kevin Federline, spending many nights away in hotels with male model Isaac Cohen, instead of going home to her two sons, Sean Preston and Jaden James.